Literature DB >> 29564126

Induced pluripotent stem cells in rat models of Parkinson's disease: A systematic review and meta-analysis.

Yunxia Zhang1,2, Meiling Ge2, Qiukui Hao2, Birong Dong2.   

Abstract

The effects of induced pluripotent stem cells (iPSCs) in 6-hydroxydopamine-lesioned rat models of Parkinson's disease (PD) have been evaluated in multiple studies. However, the results evaluating the effectiveness of iPSCs in animal models of PD are mixed, primarily due to their low statistical power. In the current study, a meta-analysis was performed to describe the treatment effect of unsorted iPSCs on behavioral testing in experimental rat models of PD. Databases searched included PubMed, EMBASE, MEDLINE and the Cochrane Library from inception to March 2017. Data were extracted for rotation behavior tests (induced by amphetamine and apomorphine) and limb function tests. A total of eight studies were included in the current meta-analysis, and iPSCs were identified to be efficacious according to the pooled standardized mean differences (SMDs) for improving amphetamine-induced rotational behavior [SMD, -2.16; 95% confidence interval (95% CI), -2.93, -1.40; P<0.00001] and apomorphine-induced rotational test (SMD, -1.45; 95% CI, -2.16, -0.73; P<0.0001). The pooled evidence indicated that iPSCs improve rotational behavior in rat models of PD. It was concluded that iPSCs provide a potential approach for developing novel treatment strategies for PD, and the results of this meta-analysis may guide future preclinical and clinical studies.

Entities:  

Keywords:  Parkinson's disease; induced pluripotent stem cells; meta-analysis

Year:  2018        PMID: 29564126      PMCID: PMC5854947          DOI: 10.3892/br.2018.1049

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  36 in total

Review 1.  Stemming the hype: what can we learn from iPSC models of Parkinson's disease and how can we learn it?

Authors:  Benjamin Meir Jacobs
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

2.  Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.

Authors:  Michela Deleidi; Gunnar Hargus; Penelope Hallett; Teresia Osborn; Ole Isacson
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

Review 3.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

4.  Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Authors:  Marios Politis; Kit Wu; Clare Loane; Niall P Quinn; David J Brooks; Stig Rehncrona; Anders Bjorklund; Olle Lindvall; Paola Piccini
Journal:  Sci Transl Med       Date:  2010-06-30       Impact factor: 17.956

5.  Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease.

Authors:  P Brundin; R E Strecker; O Lindvall; O Isacson; O G Nilsson; G Barbin; A Prochiantz; C Forni; A Nieoullon; H Widner
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

6.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

7.  Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.

Authors:  Andrzej Swistowski; Jun Peng; Qiuyue Liu; Prashant Mali; Mahendra S Rao; Linzhao Cheng; Xianmin Zeng
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

8.  Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.

Authors:  Masatoshi Inden; Kazuyuki Takata; Kaneyasu Nishimura; Yoshihisa Kitamura; Eishi Ashihara; Kanji Yoshimoto; Hiroyoshi Ariga; Osamu Honmou; Shun Shimohama
Journal:  J Neurosci Res       Date:  2012-10-17       Impact factor: 4.164

Review 9.  The 6-hydroxydopamine model: news from the past.

Authors:  Fabio Blandini; Marie-Therese Armentero; Emilia Martignoni
Journal:  Parkinsonism Relat Disord       Date:  2008-07-02       Impact factor: 4.891

10.  Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation.

Authors:  Anke Brederlau; Ana Sofia Correia; Sergey V Anisimov; Muna Elmi; Gesine Paul; Laurent Roybon; Asuka Morizane; Filip Bergquist; Ilse Riebe; Ulf Nannmark; Manolo Carta; Erik Hanse; Jun Takahashi; Yoshiki Sasai; Keiko Funa; Patrick Brundin; Peter S Eriksson; Jia-Yi Li
Journal:  Stem Cells       Date:  2006-03-23       Impact factor: 6.277

View more
  3 in total

Review 1.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

2.  Single-Cell Gene Expression Analysis and Evaluation of the Therapeutic Function of Murine Adipose-Derived Stromal Cells (ASCs) from the Subcutaneous and Visceral Compartment.

Authors:  Dominik Pförringer; Matthias M Aitzetmüller; Elizabeth A Brett; Khosrow S Houschyar; Richard Schäfer; Martijn van Griensven; Dominik Duscher
Journal:  Stem Cells Int       Date:  2018-12-11       Impact factor: 5.443

3.  Effect of Bone Marrow Stromal Cells in Parkinson's Disease Rodent Model: A Meta-Analysis.

Authors:  Jianyang Liu; Jialin He; Yan Huang; Zhiping Hu
Journal:  Front Aging Neurosci       Date:  2020-12-11       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.